Cite
HARVARD Citation
Wilkie, M. et al. (2020). A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults. Vaccine. 38 (4), pp. 779-789. [Online].